Biomarin Pharmaceutical Inc (BMRN)

05:47 AM

PTC To Challenge BioMarin In PKU With Oral Sephience - insights.citeline.com

05:47 AM

Jul 28, 2025

US FDA approves PTC Therapeutics' metabolic disorder drug - Reuters

Jul 28, 2025

Jul 28, 2025

BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Jul 28, 2025

Jul 28, 2025

Should I hold or sell BioMarin Pharmaceutical Inc. stock in 2025Achieve rapid wealth accumulation through smart investing - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What is BioMarin Pharmaceutical Inc. company’s growth strategyTrack top-performing stocks in real-time - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Leerink Partners Maintains a Buy on BioMarin Pharmaceutical (BMRN), Retains a $105 PT - Insider Monkey

Jul 28, 2025

Jul 28, 2025

Why is BioMarin Pharmaceutical Inc. stock attracting strong analyst attentionBuild wealth with reliable stock picks - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What are analysts’ price targets for BioMarin Pharmaceutical Inc. in the next 12 monthsTremendous return rates - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What catalysts could drive BioMarin Pharmaceutical Inc. stock higher in 2025Unlock exclusive trading strategies for gains - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

When is BioMarin Pharmaceutical Inc. stock expected to show significant growthConsistently outstanding ROI - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What makes BioMarin Pharmaceutical Inc. stock price move sharplyCapitalize on high-yield stocks early - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025

Jul 25, 2025

Is BioMarin Pharmaceutical Inc. a good long term investmentStrongest growth potential - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about BioMarin Pharmaceutical Inc. stockOutstanding growth strategies - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Published on: 2025-07-25 23:58:58 - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What risks could impact BioMarin Pharmaceutical Inc. stock performanceExceptional ROI - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

BioMarin’s BMN 349: A Promising Step in Genetic Lung Condition Treatment - TipRanks

Jul 24, 2025

Jul 24, 2025

Will BioMarin Pharmaceutical Inc. stock benefit from AI tech trendsFree Consultation - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET - Eastern Progress

Jul 24, 2025

Jul 23, 2025

BioMarin: Less Likely M&A Target As New Rival For Best-Selling Drug Emerges (Rating Downgrade) - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

BioMarin Pharmaceutical Inc. Stock Analysis and ForecastOutstanding growth strategies - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives BioMarin Pharmaceutical Inc. stock priceAccelerated earnings growth - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Investors Still Waiting For A Pull Back In BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - simplywall.st

Jul 22, 2025

Jul 19, 2025

BioMarin Bets On Growth, But Competition Keeps Pressure On - Finimize

Jul 19, 2025